Small proline-rich protein 2A drives epithelial remodeling in eosinophilic chronic rhinosinusitis with nasal polyps via SAA2 upregulation
- PMID: 40447198
- PMCID: PMC12277033
- DOI: 10.1016/j.jaci.2025.05.012
Small proline-rich protein 2A drives epithelial remodeling in eosinophilic chronic rhinosinusitis with nasal polyps via SAA2 upregulation
Abstract
Background: Eosinophilic chronic rhinosinusitis with nasal polyps (eCRSwNP) is a severe subtype of chronic rhinosinusitis characterized by eosinophilic inflammation, type 2 immune responses, and tissue remodeling in the sinonasal mucosa.
Objective: We sought to identify genes contributing to eCRSwNP pathogenesis and elucidate their roles in epithelial dysfunction and tissue remodeling.
Methods: Transcriptome sequencing was conducted on nasal tissues from patients with eCRSwNP, noneosinophilic CRSwNP (neCRSwNP), and healthy controls and from a CRSwNP mouse model with small proline-rich protein 2A knockout (Sprr2a-/-) mice. Epithelial-mesenchymal transition (EMT) was examined in the CRSwNP mouse model and air-liquid interface culture system with nasal epithelial cells.
Results: Transcriptomic analysis revealed that SPRR2A expression was significantly elevated in eCRSwNP nasal tissues compared with neCRSwNP and healthy controls. High SPRR2A expression correlated with increased eosinophil infiltration, epithelial thickness, and IL-13 levels. In the CRSwNP mouse model, Sprr2a-/- mice displayed reduced epithelial thickness, fewer nasal polyps, lower IL-4 and IL-13 levels, and attenuated EMT. In vitro, nasal epithelial cells from Sprr2a-/- mice demonstrated reduced EMT markers and preserved barrier integrity. Further transcriptomic analysis identified serum amyloid A3 (Saa3) as a downstream mediator of SPRR2A. Saa3 expression was reduced in Sprr2a-/- mice, whereas serum amyloid A2 (SAA2 [human]) was upregulated in eCRSwNP compared with neCRSwNP and healthy controls and positively correlated with SPRR2A levels. In air-liquid interface cultures, Saa3 induced EMT and barrier dysfunction and increased IL-6, thymic stromal lymphopoietin, IL-33, and TGF-β1 production.
Conclusions: These findings suggest that SPRR2A promotes eosinophilic inflammation and tissue remodeling via SAA2, highlighting the SPRR2A-SAA2 axis as a potential therapeutic target in eCRSwNP.
Keywords: Chronic rhinosinusitis with nasal polyps; air-liquid interface; epithelial-mesenchymal transition; serum amyloid A3; small proline-rich protein 2A; tissue remodeling.
Copyright © 2025 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure statement This study was supported by grants from the National Institutes of Health (grant nos. 1R01AI153331 and R01AI141642) and the National Natural Science Foundation of China (grant nos. 82371126, 82371127, and 82301289). Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.
Similar articles
-
Single cell transcriptomic analysis reveals transcriptome differences of different cells between eosinophilic chronic rhinosinusitis with nasal polyps and non-eosinophilic chronic rhinosinusitis with nasal polyps.PLoS One. 2025 Jul 28;20(7):e0328241. doi: 10.1371/journal.pone.0328241. eCollection 2025. PLoS One. 2025. PMID: 40720416 Free PMC article.
-
Activation of pyroptosis impairs basal cell differentiation in the nasal epithelium in chronic rhinosinusitis with nasal polyps.Mol Med Rep. 2025 Aug;32(2):229. doi: 10.3892/mmr.2025.13594. Epub 2025 Jun 13. Mol Med Rep. 2025. PMID: 40511559 Free PMC article.
-
GLUT1 Promotes Squamous Metaplasia in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps.Am J Rhinol Allergy. 2025 Sep;39(5):353-363. doi: 10.1177/19458924251342999. Epub 2025 May 19. Am J Rhinol Allergy. 2025. PMID: 40388707
-
Current Understanding of Epithelial-Derived Alarmins in Chronic Rhinosinusitis with Nasal Polyps.Clin Rev Allergy Immunol. 2025 Jun 18;68(1):59. doi: 10.1007/s12016-025-09073-y. Clin Rev Allergy Immunol. 2025. PMID: 40533675 Review.
-
Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011996. doi: 10.1002/14651858.CD011996.pub2. Cochrane Database Syst Rev. 2016. PMID: 27115217 Free PMC article.
References
-
- Fokkens WJ, Viskens AS, Backer V, Conti D, De Corso E, Gevaert P, et al. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology 2023;61:194–202. - PubMed
-
- Hopkins C Chronic rhinosinusitis with nasal polyps. N Engl J Med 2019;381: 55–63. - PubMed
-
- McCormick JP, Thompson HM, Cho DY, Woodworth BA, Grayson JW. Phenotypes in chronic rhinosinusitis. Curr Allergy Asthma Rep 2020;20:20. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous